glp-1 hfpef 🔴GLP-1 Receptor Agonist in Non-obese Patients with Type-2 Diabetes & HFpEF⤵️ 🔹GLP-1RA use is associated with improved cardiovascular outcomes in non-obese patients with T2DM and and has an associated incremental benefit Malnutrition and Sarcopenia as Reasons

Jean-Pierre Raufman , working with biochemist John Eng , discovered that the Gila monster (a desert reptile) produces in its saliva a peptide that mimics GLP-1s action but is not rapidly destroyed by DPP-4 ( [45] ) ( [46] )

Semaglutide GLP-1 is a highly effective option for those struggling with weight loss, Ozempic is a brand name of semaglutide GLP-1 that was originally approved to help manage type 2 diabetes

You may notice mild appetite reduction, but do not expect significant weight changes yet

GLP-1 short-term side effects include: Nausea Vomiting Diarrhea Constipation Headaches Fatigue Dizziness GLP-1 long-term side effects include: Ongoing and persistent irregular bowel movements Sluggish digestion Changes in gut comfort over time Impact on bone health and density Reduction in muscle mass Nutritional deficiencies Its important to note that long-term GLP-1 medication side effects have not been well-studied